148 lines
68 KiB
Text
148 lines
68 KiB
Text
<!DOCTYPE html>
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" class="no-js no-jr">
|
|
<head>
|
|
<!-- For pinger, set start time and add meta elements. -->
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books">
|
|
<meta name="ncbi_pdid" content="book-part">
|
|
<meta name="ncbi_acc" content="NBK604923">
|
|
<meta name="ncbi_domain" content="nciprotocols">
|
|
<meta name="ncbi_report" content="reader">
|
|
<meta name="ncbi_type" content="fulltext">
|
|
<meta name="ncbi_objectid" content="">
|
|
<meta name="ncbi_pcid" content="/NBK604923/?report=reader">
|
|
<meta name="ncbi_pagename" content="Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7 - National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols - NCBI Bookshelf">
|
|
<meta name="ncbi_bookparttype" content="chapter">
|
|
<meta name="ncbi_app" content="bookshelf">
|
|
<!-- Logger end -->
|
|
|
|
<!--component id="Page" label="meta"/-->
|
|
<script type="text/javascript" src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.boots.min.js"> </script><title>Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7 - National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols - NCBI Bookshelf</title>
|
|
<meta charset="utf-8">
|
|
<meta name="apple-mobile-web-app-capable" content="no">
|
|
<meta name="viewport" content="initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no">
|
|
<meta name="jr-col-layout" content="auto">
|
|
<meta name="jr-prev-unit" content="/books/n/nciprotocols/ncipr80/?report=reader">
|
|
<meta name="jr-next-unit" content="/books/n/nciprotocols/ncipr64/?report=reader">
|
|
<meta name="bk-toc-url" content="/books/n/nciprotocols/?report=toc">
|
|
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE">
|
|
<meta name="citation_inbook_title" content="National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols [Internet]">
|
|
<meta name="citation_title" content="Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7">
|
|
<meta name="citation_publisher" content="National Cancer Institute (US)">
|
|
<meta name="citation_date" content="2020/09">
|
|
<meta name="citation_author" content="Timothy M. Potter">
|
|
<meta name="citation_author" content="Edward Cedrone">
|
|
<meta name="citation_author" content="Barry W. Neun">
|
|
<meta name="citation_author" content="Marina A. Dobrovolskaia">
|
|
<meta name="citation_pmid" content="39013045">
|
|
<meta name="citation_doi" content="10.17917/T6JC-ZG30">
|
|
<meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK604923/">
|
|
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/">
|
|
<meta name="DC.Title" content="Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7">
|
|
<meta name="DC.Type" content="Text">
|
|
<meta name="DC.Publisher" content="National Cancer Institute (US)">
|
|
<meta name="DC.Contributor" content="Timothy M. Potter">
|
|
<meta name="DC.Contributor" content="Edward Cedrone">
|
|
<meta name="DC.Contributor" content="Barry W. Neun">
|
|
<meta name="DC.Contributor" content="Marina A. Dobrovolskaia">
|
|
<meta name="DC.Date" content="2020/09">
|
|
<meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK604923/">
|
|
<meta name="description" content="This document describes a protocol for quantitative determination of nitrite (NO2−), a stable oxidative end-product of the antimicrobial effector molecule nitric oxide in cell culture medium [1, 2]. The protocol is used to evaluate the capability of nanomaterials to induce nitric oxide production by macrophages. Nitric oxide secreted by macrophages has a half-life of seconds and interacts with a number of different molecular targets, resulting in cytotoxicity. In the presence of oxygen and water, nitric oxide interacts with itself to generate other reactive nitrogen oxide intermediates and ultimately decomposes to form nitrite (NO2−) and nitrate (NO3−). Interestingly, despite expression of inducible nitric oxide synthase (iNOS), an enzyme responsible for the generation of nitric oxide in both human and mouse immune cells, the induction of nitric oxide by immunologically active agonists (e.g., bacterial lipopolysaccharide) and the levels of produced nitric oxide are different between human and mouse immune cells [3]. The response in human immune cells, especially under in vitro conditions is substantially lower than in murine cells. For this reason, a murine macrophage cell line is a better model for in vitro analysis of nitric oxide production than human monocytes and macrophages.">
|
|
<meta name="og:title" content="Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7">
|
|
<meta name="og:type" content="book">
|
|
<meta name="og:description" content="This document describes a protocol for quantitative determination of nitrite (NO2−), a stable oxidative end-product of the antimicrobial effector molecule nitric oxide in cell culture medium [1, 2]. The protocol is used to evaluate the capability of nanomaterials to induce nitric oxide production by macrophages. Nitric oxide secreted by macrophages has a half-life of seconds and interacts with a number of different molecular targets, resulting in cytotoxicity. In the presence of oxygen and water, nitric oxide interacts with itself to generate other reactive nitrogen oxide intermediates and ultimately decomposes to form nitrite (NO2−) and nitrate (NO3−). Interestingly, despite expression of inducible nitric oxide synthase (iNOS), an enzyme responsible for the generation of nitric oxide in both human and mouse immune cells, the induction of nitric oxide by immunologically active agonists (e.g., bacterial lipopolysaccharide) and the levels of produced nitric oxide are different between human and mouse immune cells [3]. The response in human immune cells, especially under in vitro conditions is substantially lower than in murine cells. For this reason, a murine macrophage cell line is a better model for in vitro analysis of nitric oxide production than human monocytes and macrophages.">
|
|
<meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK604923/">
|
|
<meta name="og:site_name" content="NCBI Bookshelf">
|
|
<meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-nciprotocols-lrg.png">
|
|
<meta name="twitter:card" content="summary">
|
|
<meta name="twitter:site" content="@ncbibooks">
|
|
<meta name="bk-non-canon-loc" content="/books/n/nciprotocols/ncipr65/?report=reader">
|
|
<link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK604923/">
|
|
<link href="https://fonts.googleapis.com/css?family=Archivo+Narrow:400,700,400italic,700italic&subset=latin" rel="stylesheet" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/libs.min.css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/jr.min.css">
|
|
<meta name="format-detection" content="telephone=no">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css//books_print.min.css" type="text/css" media="print">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_reader.min.css" type="text/css">
|
|
<style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style>
|
|
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico">
|
|
<meta name="ncbi_phid" content="CE8E4FA37C8EA0F10000000000A50094.m_5">
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3849091.css"></head>
|
|
<body>
|
|
<!-- Book content! -->
|
|
|
|
|
|
<div id="jr" data-jr-path="/corehtml/pmc/jatsreader/ptpmc_3.22/"><div class="jr-unsupported"><table class="modal"><tr><td><span class="attn inline-block"></span><br />Your browser does not support the NLM PubReader view.<br />Go to <a href="/pmc/about/pr-browsers/">this page</a> to see a list of supported browsers<br />or return to the <br /><a href="/books/NBK604923/?report=classic">regular view</a>.</td></tr></table></div><div id="jr-ui" class="hidden"><nav id="jr-head"><div class="flexh tb"><div id="jr-tb1"><a id="jr-links-sw" class="hidden" title="Links"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" x="0px" y="0px" viewBox="0 0 70.6 85.3" style="enable-background:new 0 0 70.6 85.3;vertical-align:middle" xml:space="preserve" width="24" height="24">
|
|
<style type="text/css">.st0{fill:#939598;}</style>
|
|
<g>
|
|
<path class="st0" d="M36,0C12.8,2.2-22.4,14.6,19.6,32.5C40.7,41.4-30.6,14,35.9,9.8"></path>
|
|
<path class="st0" d="M34.5,85.3c23.2-2.2,58.4-14.6,16.4-32.5c-21.1-8.9,50.2,18.5-16.3,22.7"></path>
|
|
<path class="st0" d="M34.7,37.1c66.5-4.2-4.8-31.6,16.3-22.7c42.1,17.9,6.9,30.3-16.4,32.5h1.7c-66.2,4.4,4.8,31.6-16.3,22.7 c-42.1-17.9-6.9-30.3,16.4-32.5"></path>
|
|
</g>
|
|
</svg> Books</a></div><div class="jr-rhead f1 flexh"><div class="head"><a href="/books/n/nciprotocols/ncipr80/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="body"><div class="t">NCL Method ITA-7, Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7: Version 2</div><div class="j">National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols [Internet]</div></div><div class="tail"><a href="/books/n/nciprotocols/ncipr64/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></div><div id="jr-tb2"><a id="jr-bkhelp-sw" class="btn wsprkl hidden" title="Help with NLM PubReader">?</a><a id="jr-help-sw" class="btn wsprkl hidden" title="Settings and typography in NLM PubReader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" preserveAspectRatio="none"><path d="M462,283.742v-55.485l-29.981-10.662c-11.431-4.065-20.628-12.794-25.274-24.001 c-0.002-0.004-0.004-0.009-0.006-0.013c-4.659-11.235-4.333-23.918,0.889-34.903l13.653-28.724l-39.234-39.234l-28.72,13.652 c-10.979,5.219-23.68,5.546-34.908,0.889c-0.005-0.002-0.01-0.003-0.014-0.005c-11.215-4.65-19.933-13.834-24-25.273L283.741,50 h-55.484l-10.662,29.981c-4.065,11.431-12.794,20.627-24.001,25.274c-0.005,0.002-0.009,0.004-0.014,0.005 c-11.235,4.66-23.919,4.333-34.905-0.889l-28.723-13.653l-39.234,39.234l13.653,28.721c5.219,10.979,5.545,23.681,0.889,34.91 c-0.002,0.004-0.004,0.009-0.006,0.013c-4.649,11.214-13.834,19.931-25.271,23.998L50,228.257v55.485l29.98,10.661 c11.431,4.065,20.627,12.794,25.274,24c0.002,0.005,0.003,0.01,0.005,0.014c4.66,11.236,4.334,23.921-0.888,34.906l-13.654,28.723 l39.234,39.234l28.721-13.652c10.979-5.219,23.681-5.546,34.909-0.889c0.005,0.002,0.01,0.004,0.014,0.006 c11.214,4.649,19.93,13.833,23.998,25.271L228.257,462h55.484l10.595-29.79c4.103-11.538,12.908-20.824,24.216-25.525 c0.005-0.002,0.009-0.004,0.014-0.006c11.127-4.628,23.694-4.311,34.578,0.863l28.902,13.738l39.234-39.234l-13.66-28.737 c-5.214-10.969-5.539-23.659-0.886-34.877c0.002-0.005,0.004-0.009,0.006-0.014c4.654-11.225,13.848-19.949,25.297-24.021 L462,283.742z M256,331.546c-41.724,0-75.548-33.823-75.548-75.546s33.824-75.547,75.548-75.547 c41.723,0,75.546,33.824,75.546,75.547S297.723,331.546,256,331.546z"></path></svg></a><a id="jr-fip-sw" class="btn wsprkl hidden" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-rtoc-sw" class="btn wsprkl hidden" title="Table of Contents"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,20h10v8H20V20zM36,20h44v8H36V20zM20,37.33h10v8H20V37.33zM36,37.33h44v8H36V37.33zM20,54.66h10v8H20V54.66zM36,54.66h44v8H36V54.66zM20,72h10v8 H20V72zM36,72h44v8H36V72z"></path></svg></a></div></div></nav><nav id="jr-dash" class="noselect"><nav id="jr-dash" class="noselect"><div id="jr-pi" class="hidden"><a id="jr-pi-prev" class="hidden" title="Previous page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a><div class="pginfo">Page <i class="jr-pg-pn">0</i> of <i class="jr-pg-lp">0</i></div><a id="jr-pi-next" class="hidden" title="Next page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div><div id="jr-is-tb"><a id="jr-is-sw" class="btn wsprkl hidden" title="Switch between Figures/Tables strip and Progress bar"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><rect x="10" y="40" width="20" height="20"></rect><rect x="40" y="40" width="20" height="20"></rect><rect x="70" y="40" width="20" height="20"></rect></svg></a></div><nav id="jr-istrip" class="istrip hidden"><a id="jr-is-prev" href="#" class="hidden" title="Previous"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M80,40 60,65 80,90 70,90 50,65 70,40z M50,40 30,65 50,90 40,90 20,65 40,40z"></path><text x="35" y="25" textLength="60" style="font-size:25px">Prev</text></svg></a><a id="jr-is-next" href="#" class="hidden" title="Next"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,40 40,65 20,90 30,90 50,65 30,40z M50,40 70,65 50,90 60,90 80,65 60,40z"></path><text x="15" y="25" textLength="60" style="font-size:25px">Next</text></svg></a></nav><nav id="jr-progress"></nav></nav></nav><aside id="jr-links-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">NCBI Bookshelf</div></div><div class="cnt lol f1"><a href="/books/">Home</a><a href="/books/browse/">Browse All Titles</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/sharer/sharer.php?u=https://www.ncbi.nlm.nih.gov/books/NBK604923/"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24" preserveAspectRatio="none"><g><path d="M 17.996,32L 12,32 L 12,16 l-4,0 l0-5.514 l 4-0.002l-0.006-3.248C 11.993,2.737, 13.213,0, 18.512,0l 4.412,0 l0,5.515 l-2.757,0 c-2.063,0-2.163,0.77-2.163,2.209l-0.008,2.76l 4.959,0 l-0.585,5.514L 18,16L 17.996,32z"></path></g></svg> Share on Facebook</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://twitter.com/intent/tweet?url=https://www.ncbi.nlm.nih.gov/books/NBK604923/&text=Detection%20of%20Nitric%20Oxide%20Production%20by%20the%20Macrophage%20Cell%20Line%20RAW264.7"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24"><g><path d="M 32,6.076c-1.177,0.522-2.443,0.875-3.771,1.034c 1.355-0.813, 2.396-2.099, 2.887-3.632 c-1.269,0.752-2.674,1.299-4.169,1.593c-1.198-1.276-2.904-2.073-4.792-2.073c-3.626,0-6.565,2.939-6.565,6.565 c0,0.515, 0.058,1.016, 0.17,1.496c-5.456-0.274-10.294-2.888-13.532-6.86c-0.565,0.97-0.889,2.097-0.889,3.301 c0,2.278, 1.159,4.287, 2.921,5.465c-1.076-0.034-2.088-0.329-2.974-0.821c-0.001,0.027-0.001,0.055-0.001,0.083 c0,3.181, 2.263,5.834, 5.266,6.438c-0.551,0.15-1.131,0.23-1.73,0.23c-0.423,0-0.834-0.041-1.235-0.118 c 0.836,2.608, 3.26,4.506, 6.133,4.559c-2.247,1.761-5.078,2.81-8.154,2.81c-0.53,0-1.052-0.031-1.566-0.092 c 2.905,1.863, 6.356,2.95, 10.064,2.95c 12.076,0, 18.679-10.004, 18.679-18.68c0-0.285-0.006-0.568-0.019-0.849 C 30.007,8.548, 31.12,7.392, 32,6.076z"></path></g></svg> Share on Twitter</a></div></aside><aside id="jr-rtoc-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Table of Content</div></div><div class="cnt lol f1"><a href="/books/n/nciprotocols/?report=reader">Title Information</a><a href="/books/n/nciprotocols/toc/?report=reader">Table of Contents Page</a></div></aside><aside id="jr-help-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Settings</div></div><div class="cnt f1"><div id="jr-typo-p" class="typo"><div><a class="sf btn wsprkl">A-</a><a class="lf btn wsprkl">A+</a></div><div><a class="bcol-auto btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 200 100" preserveAspectRatio="none"><text x="10" y="70" style="font-size:60px;font-family: Trebuchet MS, ArialMT, Arial, sans-serif" textLength="180">AUTO</text></svg></a><a class="bcol-1 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M15,25 85,25zM15,40 85,40zM15,55 85,55zM15,70 85,70z"></path></svg></a><a class="bcol-2 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M5,25 45,25z M55,25 95,25zM5,40 45,40z M55,40 95,40zM5,55 45,55z M55,55 95,55zM5,70 45,70z M55,70 95,70z"></path></svg></a></div></div><div class="lol"><a class="" href="/books/NBK604923/?report=classic">Switch to classic view</a><a href="/books/NBK604923/pdf/Bookshelf_NBK604923.pdf">PDF (429K)</a><a href="/books/NBK604923/?report=printable">Print View</a></div></div></aside><aside id="jr-bkhelp-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Help</div></div><div class="cnt f1 lol"><a id="jr-helpobj-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/help.xml" href="">Help</a><a href="mailto:info@ncbi.nlm.nih.gov?subject=PubReader%20feedback%20%2F%20NBK604923%20%2F%20sid%3ACE8B5AF87C7FFCB1_0191SID%20%2F%20phid%3ACE8E4FA37C8EA0F10000000000A50094.4">Send us feedback</a><a id="jr-about-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/about.xml" href="">About PubReader</a></div></aside><aside id="jr-objectbox" class="thidden hidden"><div class="jr-objectbox-close wsprkl">✘</div><div class="jr-objectbox-inner cnt"><div class="jr-objectbox-drawer"></div></div></aside><nav id="jr-pm-left" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Previous Page</text></svg></nav><nav id="jr-pm-right" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Next Page</text></svg></nav><nav id="jr-fip" class="hidden"><nav id="jr-fip-term-p"><input type="search" placeholder="search this page" id="jr-fip-term" autocorrect="off" autocomplete="off" /><a id="jr-fip-mg" class="wsprkl btn" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-fip-done" class="wsprkl btn" title="Dismiss find">✘</a></nav><nav id="jr-fip-info-p"><a id="jr-fip-prev" class="wsprkl btn" title="Jump to previuos match">◀</a><button id="jr-fip-matches">no matches yet</button><a id="jr-fip-next" class="wsprkl btn" title="Jump to next match">▶</a></nav></nav></div><div id="jr-epub-interstitial" class="hidden"></div><div id="jr-content"><article data-type="main"><div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><div class="fm-sec"><h1 id="_NBK604923_"><span class="label">NCL Method ITA-7</span><span class="title" itemprop="name">Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7</span></h1><div class="subtitle whole_rhythm">Version 2</div><p class="contribs">Potter TM, Cedrone E, Neun BW, et al.</p><p class="fm-aai"><a href="#_NBK604923_pubdet_">Publication Details</a></p></div></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ncipr65.s1"><h2 id="_ncipr65_s1_">1. Introduction</h2><p>This document describes a protocol for quantitative determination of nitrite (NO<sub>2</sub><sup>−</sup>), a stable oxidative end-product of the antimicrobial effector molecule nitric oxide in cell culture medium [<a class="bibr" href="#ncipr65.ref1" rid="ncipr65.ref1">1</a>, <a class="bibr" href="#ncipr65.ref2" rid="ncipr65.ref2">2</a>]. The protocol is used to evaluate the capability of nanomaterials to induce nitric oxide production by macrophages. Nitric oxide secreted by macrophages has a half-life of seconds and interacts with a number of different molecular targets, resulting in cytotoxicity. In the presence of oxygen and water, nitric oxide interacts with itself to generate other reactive nitrogen oxide intermediates and ultimately decomposes to form nitrite (NO<sub>2</sub><sup>−</sup>) and nitrate (NO<sub>3</sub><sup>−</sup>). Interestingly, despite expression of inducible nitric oxide synthase (iNOS), an enzyme responsible for the generation of nitric oxide in both human and mouse immune cells, the induction of nitric oxide by immunologically active agonists (e.g., bacterial lipopolysaccharide) and the levels of produced nitric oxide are different between human and mouse immune cells [<a class="bibr" href="#ncipr65.ref3" rid="ncipr65.ref3">3</a>]. The response in human immune cells, especially under in vitro conditions is substantially lower than in murine cells. For this reason, a murine macrophage cell line is a better model for in vitro analysis of nitric oxide production than human monocytes and macrophages.</p></div><div id="ncipr65.s2"><h2 id="_ncipr65_s2_">2. Principles</h2><p>In this assay, nitrite is measured in tissue culture medium using the Griess reagent. This measurement provides a surrogate marker and quantitative indicator of nitric oxide production. The murine macrophage cell line RAW 264.7 is used as the model in this assay. The upper and the lower limit of quantification are 250 μM and 1.95 μM of nitrate, respectively.</p></div><div id="ncipr65.s3"><h2 id="_ncipr65_s3_">3. Reagents, Materials, Cell Lines, and Equipment</h2><blockquote><p><i>Note: The NCL does not endorse any of the suppliers listed below; these reagents were used in the development of the protocol and their inclusion is for informational purposes only. Equivalent supplies from alternate vendors can be substituted. Please note that suppliers may undergo a name change due to a variety of factors. Brands and part numbers typically remain consistent but may also change over time</i>.</p></blockquote><dl id="ncipr65.l1" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>3.1.</dt><dd id="ncipr65.lt1"><p class="no_top_margin">Reagents
|
|
<dl id="ncipr65.l2" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>3.1.1.</dt><dd id="ncipr65.lt2"><p class="no_top_margin">Phosphate buffered saline (PBS) (GE Life Sciences, SH30256.01)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.2.</dt><dd id="ncipr65.lt3"><p class="no_top_margin">LPS-EK UltraPure (<i>E. coli K12)</i> or equivalent (Invivogen, tlrl-peklps)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.3.</dt><dd id="ncipr65.lt4"><p class="no_top_margin">Fetal bovine serum (FBS) (GE Life Sciences, Hyclone, SH30070.03)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.4.</dt><dd id="ncipr65.lt5"><p class="no_top_margin">RPMI-1640 <b><u>without phenol red</u></b> (GE Life Sciences, Hyclone, SH30605.01)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.5.</dt><dd id="ncipr65.lt6"><p class="no_top_margin">Hanks balanced salt solution (HBSS) (Gibco, 24020-117)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.6.</dt><dd id="ncipr65.lt7"><p class="no_top_margin">Penicillin streptomycin solution (GE Life Sciences, Hyclone, SV30010)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.7.</dt><dd id="ncipr65.lt8"><p class="no_top_margin">L-glutamine (GE Life Sciences, Hyclone, SH30034.01)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.8.</dt><dd id="ncipr65.lt9"><p class="no_top_margin">β-mercaptoethanol (Sigma-Aldrich, M7522)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.9.</dt><dd id="ncipr65.lt10"><p class="no_top_margin">Trypan Blue solution (Gibco, 15250-061)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.10.</dt><dd id="ncipr65.lt11"><p class="no_top_margin">Naphthylethylenediamine dihydrochloride (Sigma-Aldrich, N9125)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.11.</dt><dd id="ncipr65.lt12"><p class="no_top_margin">Sulfanilamide (Sigma-Aldrich, S9251)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.12.</dt><dd id="ncipr65.lt13"><p class="no_top_margin">Phosphoric acid, 1N (Sigma-Aldrich, 438081)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.13.</dt><dd id="ncipr65.lt14"><p class="no_top_margin">Sodium Nitrite (NaNO<sub>2</sub>) Standard, 1 M stock solution (Fisher, 60-026-33)</p></dd></dl></dl></p></dd></dl><dl class="bkr_refwrap"><dt>3.2.</dt><dd id="ncipr65.lt15"><p class="no_top_margin">Materials
|
|
<dl id="ncipr65.l3" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>3.2.1.</dt><dd id="ncipr65.lt16"><p class="no_top_margin">Pipettes, 0.05 to 10 mL</p></dd></dl><dl class="bkr_refwrap"><dt>3.2.2.</dt><dd id="ncipr65.lt17"><p class="no_top_margin">Multichannel pipettor</p></dd></dl><dl class="bkr_refwrap"><dt>3.2.3.</dt><dd id="ncipr65.lt18"><p class="no_top_margin">Flat bottom 96-well plates</p></dd></dl><dl class="bkr_refwrap"><dt>3.2.4.</dt><dd id="ncipr65.lt19"><p class="no_top_margin">24-well plates</p></dd></dl><dl class="bkr_refwrap"><dt>3.2.5.</dt><dd id="ncipr65.lt20"><p class="no_top_margin">Polypropylene tubes, 50 and 15 mL</p></dd></dl><dl class="bkr_refwrap"><dt>3.2.6.</dt><dd id="ncipr65.lt21"><p class="no_top_margin">Reagent reservoirs</p></dd></dl></dl></p></dd></dl><dl class="bkr_refwrap"><dt>3.3.</dt><dd id="ncipr65.lt22"><p class="no_top_margin">Cell Lines
|
|
<dl id="ncipr65.l4" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>3.3.1.</dt><dd id="ncipr65.lt23"><p class="no_top_margin">RAW 264.7 murine macrophages</p></dd></dl></dl></p></dd></dl><dl class="bkr_refwrap"><dt>3.4.</dt><dd id="ncipr65.lt24"><p class="no_top_margin">Equipment
|
|
<dl id="ncipr65.l5" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>3.4.1.</dt><dd id="ncipr65.lt25"><p class="no_top_margin">Centrifuge</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.2.</dt><dd id="ncipr65.lt26"><p class="no_top_margin">Refrigerator, 2-8°C</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.3.</dt><dd id="ncipr65.lt27"><p class="no_top_margin">Freezer, −20°C</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.4.</dt><dd id="ncipr65.lt28"><p class="no_top_margin">Cell culture incubator, 5% CO<sub>2</sub> and 95% humidity</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.5.</dt><dd id="ncipr65.lt29"><p class="no_top_margin">Biohazard safety cabinet approved for level II handling of biological material</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.6.</dt><dd id="ncipr65.lt30"><p class="no_top_margin">Inverted microscope</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.7.</dt><dd id="ncipr65.lt31"><p class="no_top_margin">Vortex</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.8.</dt><dd id="ncipr65.lt32"><p class="no_top_margin">Hemocytometer</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.9.</dt><dd id="ncipr65.lt33"><p class="no_top_margin">Plate shaker</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.10.</dt><dd id="ncipr65.lt34"><p class="no_top_margin">Plate reader capable of operating at 550 nm</p></dd></dl></dl></p></dd></dl></dl></div><div id="ncipr65.s4"><h2 id="_ncipr65_s4_">4. Reagent and Control Preparation</h2><dl id="ncipr65.l6" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>4.1.</dt><dd id="ncipr65.lt35"><p class="no_top_margin">
|
|
<u>Heat-Inactivated Fetal Bovine Serum</u>
|
|
</p><p>Thaw a bottle of FBS at room temperature, or overnight at 2-8°C, and allow to equilibrate to room temperature. Incubate 30 minutes at 56°C in a water bath, mixing every 5 minutes. Single use aliquots may be stored at 2-8°C for up to one month or at a nominal temperature of −20°C indefinitely.</p></dd></dl><dl class="bkr_refwrap"><dt>4.2.</dt><dd id="ncipr65.lt36"><p class="no_top_margin">
|
|
<u>Complete RPMI-1640 Medium</u>
|
|
</p><p>The complete RPMI medium should contain the following reagents:</p><p>10% FBS (heat inactivated)</p><p>2 mM L-glutamine</p><p>50 μM β-mercaptoethanol</p><p>100 U/mL penicillin</p><p>100 μg/mL streptomycin sulfate</p><p>Store at 2-8°C protected from light for no longer than 1 month. Before use, warm in a water bath.</p></dd></dl><dl class="bkr_refwrap"><dt>4.3.</dt><dd id="ncipr65.lt37"><p class="no_top_margin">
|
|
<u>Lipopolysaccharide 1 mg/mL (LPS, Stock)</u>
|
|
</p><p>K12 LPS is provided as lyophilized powder. Reconstitute the powder by adding 1 mL of water per 1 mg of LPS to the vial and vortex to mix. Stocks with higher concentration (5-10 mg/mL) can also be prepared. Store daily use aliquots at a nominal temperature of −20°C. Avoid repeated freezing/thawing.</p></dd></dl><dl class="bkr_refwrap"><dt>4.4.</dt><dd id="ncipr65.lt38"><p class="no_top_margin">
|
|
<u>Positive Control</u>
|
|
</p><p>On the day of experiment thaw a stock aliquot at room temperature, vortex well and dilute this stock LPS solution in cell culture medium to a final concentration of 100 ng/mL. Store at room temperature during the experiment, and discard unused portion after use.</p></dd></dl><dl class="bkr_refwrap"><dt>4.5.</dt><dd id="ncipr65.lt39"><p class="no_top_margin">
|
|
<u>Negative Control</u>
|
|
</p><p>Use PBS as a negative control. Process this sample the same way you do study samples. For example, if stock nanoparticle test samples are diluted 1:10 in complete culture medium, dilute PBS 1:10 in complete culture medium and use this sample as the negative control.</p></dd></dl><dl class="bkr_refwrap"><dt>4.6.</dt><dd id="ncipr65.lt40"><p class="no_top_margin">
|
|
<u>Vehicle Control</u>
|
|
</p><p>Vehicle control is the buffer or media used to formulate test nanomaterials. Common excipients used in nanoformulations are trehalose, sucrose, and albumin. However, other reagents and materials are also used alone or in combination. Vehicle control should match formulation buffer of the test-nanomaterial by both composition and concentration. This control can be skipped if nanoparticles are stored in PBS.</p></dd></dl><dl class="bkr_refwrap"><dt>4.7.</dt><dd id="ncipr65.lt41"><p class="no_top_margin"><u>Griess Reagent</u>
|
|
<ol id="ncipr65.l7" class="upper-alpha"><li id="ncipr65.lt42" class="half_rhythm"><div>Dissolve sulfanilamide in 2.5% phosphoric acid (H<sub>3</sub>PO<sub>4</sub>) to a final concentration of 1% (w/v), e.g. dissolve 1 g of sulfanilamide in 100 mL of 2.5% H<sub>3</sub>PO<sub>4</sub>.</div></li><li id="ncipr65.lt43" class="half_rhythm"><div>Dissolve naphthylethylenediamine dihydrochloride in 2.5% H<sub>3</sub>PO<sub>4</sub> to a final concentration of 0.1% (w/v), e.g. dissolve 100 mg of naphthylethylenediamine dihydrochloride in 100 mL of 2.5% H<sub>3</sub>PO<sub>4</sub>.</div></li></ol></p><p>Store both solutions in glass bottles at 4°C; discard if discoloration occurs or solutions are not clear. Equal volumes of reagents A and B will be combined just prior to use to form the Griess reagent. This solution should be used immediately after preparation and any remaining should be discarded.</p></dd></dl><dl class="bkr_refwrap"><dt>4.8.</dt><dd id="ncipr65.lt44"><p class="no_top_margin">
|
|
<u>Preparation of NaNO<sub>2</sub> Calibration Standards</u>
|
|
</p><p>First dilute the 1N stock (<a href="#ncipr65.lt14">section 3.1.13</a>) 1:10 in distilled water then proceed as in the example shown in the table below. Volumes can be adjusted based on need.</p></dd></dl><dl class="bkr_refwrap"><dt>4.9.</dt><dd id="ncipr65.lt45"><p class="no_top_margin">
|
|
<u>Preparation of NaNO<sub>2</sub> Quality Controls</u>
|
|
</p><p>As in <a href="#ncipr65.lt44">section 4.8</a> above, start with a 1:10 dilution of stock reagent (<a href="#ncipr65.lt14">section 3.1.13</a>) Example is shown in the table below. Volumes can be adjusted based on need.</p></dd></dl></dl><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figncipr65tab1"><a href="/books/NBK604923/table/ncipr65.tab1/?report=objectonly" target="object" title="Table 1" class="img_link icnblk_img" rid-ob="figobncipr65tab1"><img class="small-thumb" src="/corehtml/pmc/css/bookshelf/2.26/img/table-icon.gif" alt="Table Icon" /></a><div class="icnblk_cntnt"><h4 id="ncipr65.tab1"><a href="/books/NBK604923/table/ncipr65.tab1/?report=objectonly" target="object" rid-ob="figobncipr65tab1">Table 1</a></h4><p class="float-caption no_bottom_margin">Preparation of Calibration Standards. </p></div></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figncipr65tab2"><a href="/books/NBK604923/table/ncipr65.tab2/?report=objectonly" target="object" title="Table 2" class="img_link icnblk_img" rid-ob="figobncipr65tab2"><img class="small-thumb" src="/corehtml/pmc/css/bookshelf/2.26/img/table-icon.gif" alt="Table Icon" /></a><div class="icnblk_cntnt"><h4 id="ncipr65.tab2"><a href="/books/NBK604923/table/ncipr65.tab2/?report=objectonly" target="object" rid-ob="figobncipr65tab2">Table 2</a></h4><p class="float-caption no_bottom_margin">Preparation of Quality Controls. </p></div></div></div><div id="ncipr65.s5"><h2 id="_ncipr65_s5_">5. Preparation of Study Samples</h2><p>This assay requires 2.5 mL of nanoparticles at 1X the highest final test concentration dissolved/resuspended in complete culture medium. The concentration is selected based on the plasma concentration of the nanoparticle at the intended therapeutic dose. For the purpose of this protocol, this concentration is called the “theoretical plasma concentration”. Considerations for estimating theoretical plasma concentration were reviewed elsewhere [<a class="bibr" href="#ncipr65.ref4" rid="ncipr65.ref4">4</a>] and are summarized in <a href="/books/NBK604923/box/ncipr65.box1/?report=objectonly" target="object" rid-ob="figobncipr65box1">Box 1</a> below.</p><p>The assay will evaluate four concentrations: 10X (or when feasible 100X or 30X; or 5X if 10X is not feasible) of the theoretical plasma concentration, the theoretical plasma concentration, and two 1:5 serial dilutions of the theoretical plasma concentration. When the intended therapeutic concentration is unknown, the highest final concentration is 1 mg/mL or the highest reasonably achievable concentration.</p><p>For example, if the final theoretical plasma concentration to be tested is 0.2 mg/mL, then a stock of 2 mg/mL will be prepared and diluted 10-fold (0.2 mg/mL), followed by two 1:5 serial dilutions (0.04 and 0.008 mg/mL). Use 500 μL of each of these samples per well. Each nanoparticle concentration is plated 3 times.</p><div id="ncipr65.box1" class="box boxed-text-box whole_rhythm hide-overflow"><h3><span class="label">Box 1</span><span class="title">Example Calculation to Determine Nanoparticle Concentration for In Vitro Tests</span></h3><p>In this example, we assume a mouse dose of 123 mg/kg. Therefore, the scaled equivalent human dose would be:
|
|
<div class="pmc_disp_formula whole_rhythm clearfix" id="ncipr65.deq1"><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow twelve_col"><math id="ncipr65.eq1" display="block"><mrow><mi>H</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>d</mi><mi>o</mi><mi>s</mi><mi>e</mi><mo>=</mo><mfrac><mrow><mi>m</mi><mi>o</mi><mi>u</mi><mi>s</mi><mi>e</mi><mtext> </mtext><mi>d</mi><mi>o</mi><mi>s</mi><mi>e</mi></mrow><mrow><mn>12.3</mn></mrow></mfrac><mo>=</mo><mfrac><mrow><mn>123</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>k</mi><mi>g</mi></mrow><mrow><mn>12.3</mn></mrow></mfrac><mo>=</mo><mn>10</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>k</mi><mi>g</mi></mrow></math></div><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow last bk_equ_label "><div><span class="nowrap"></span></div></div></div>
|
|
</p><p>Blood volume constitutes approximately 8% of the body weight. Therefore, an average human of 70 kg body weight has approximately 5.6 L of blood. Assuming all the nanoparticle injected goes into the systemic circulation, this provides a rough approximation of the potential maximum nanoparticle concentration in blood, which is used as the in vitro test concentration.</p><div class="pmc_disp_formula whole_rhythm clearfix" id="ncipr65.deq2"><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow twelve_col">
|
|
<math id="ncipr65.eq2" display="block"><mrow><mi>i</mi><mi>n</mi><mtext> </mtext><mi>v</mi><mi>i</mi><mi>t</mi><mi>r</mi><mi>o</mi><mtext> </mtext><mi>c</mi><mi>o</mi><mi>n</mi><mi>c</mi><mi>e</mi><mi>n</mi><mi>t</mi><mi>r</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><msub><mi>n</mi><mrow><mi>h</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>m</mi><mi>a</mi><mi>t</mi><mi>r</mi><mi>i</mi><mi>x</mi></mrow></msub><mo>=</mo><mfrac><mrow><mi>h</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>d</mi><mi>o</mi><mi>s</mi><mi>e</mi></mrow><mrow><mi>h</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>b</mi><mi>l</mi><mi>o</mi><mi>o</mi><mi>d</mi><mtext> </mtext><mi>v</mi><mi>o</mi><mi>l</mi><mi>u</mi><mi>m</mi><mi>e</mi></mrow></mfrac><mo>=</mo><mfrac><mrow><mn>70</mn><mo> </mo><mi>k</mi><mi>g</mi><mo>*</mo><mn>10</mn><mi>m</mi><mi>g</mi><mo>/</mo><mi>k</mi><mi>g</mi></mrow><mrow><mn>5.6</mn><mo> </mo><mi>L</mi></mrow></mfrac><mo>=</mo><mn>0.125</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>m</mi><mi>L</mi></mrow></math>
|
|
</div><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow last bk_equ_label "><div><span class="nowrap"></span></div></div></div></div></div><div id="ncipr65.s6"><h2 id="_ncipr65_s6_">6. Cell Preparation</h2><p>Raw 264.7 is a murine macrophage cell line. Grow cells in complete medium. Dislodge the cells using trypsin-EDTA solution and re-suspend in complete medium. A sub-cultivation ratio of 1:3 to 1:6 is recommended. Replace or add medium every 2 to 3 days.</p></div><div id="ncipr65.s7"><h2 id="_ncipr65_s7_">7. Experimental Procedure</h2><dl id="ncipr65.l8" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>7.1.</dt><dd id="ncipr65.lt46"><p class="no_top_margin">Adjust cell concentration to 1 x 10<sup>5</sup> cells/mL using complete RPMI medium.</p></dd></dl><dl class="bkr_refwrap"><dt>7.2.</dt><dd id="ncipr65.lt47"><p class="no_top_margin">Plate 1000 μL of cell suspension per well in a 24 well plate. Prepare triplicate wells for each sample and duplicate wells for each control. Always leave 1 cell-free well per nanoparticle concentration per plate. These wells will be used to assess potential nanoparticle interference with the assay. This is the “Culture Plate”.</p></dd></dl><dl class="bkr_refwrap"><dt>7.3.</dt><dd id="ncipr65.lt48"><p class="no_top_margin">Incubate the “Culture Plate” 24 hr in a humidified 37°C, 5% CO<sub>2</sub> incubator.</p></dd></dl><dl class="bkr_refwrap"><dt>7.4.</dt><dd id="ncipr65.lt49"><p class="no_top_margin">Remove culture medium and add 500 μL of study samples, controls, or medium blank to appropriate wells. Position samples on the plate such that study samples are bracketed by controls and blank medium.</p></dd></dl><dl class="bkr_refwrap"><dt>7.5.</dt><dd id="ncipr65.lt50"><p class="no_top_margin">Incubate the “Culture Plate” 48 ± 1 hr in a humidified 37°C, 5% CO<sub>2</sub> incubator.</p></dd></dl><dl class="bkr_refwrap"><dt>7.6.</dt><dd id="ncipr65.lt51"><p class="no_top_margin">To a fresh 96 well plate, add 50 μL per well of reagent blank [culture medium used to prepare calibration standards and quality controls], calibration standards, quality controls and medium from each well of the “Culture plate”. Load duplicate wells for each sample and control. This is the “NO<sup>−</sup> Test Plate”.
|
|
<blockquote><p><i>Note: Removal of nanoparticles from culture medium may be required prior to this step if nanoparticles can interfere with assay, e.g. if particles react with either or both components of the Griess reagent or have absorbance at or close to 550 nm. If particle removal is not feasible, results obtained for “particles only” control may be subtracted from that obtained for particle test-sample to correct for particle background interference</i>.</p></blockquote></p></dd></dl><dl class="bkr_refwrap"><dt>7.7.</dt><dd id="ncipr65.lt52"><p class="no_top_margin">In a separate tube combine equal volumes of reagent A and reagent B; this is the Griess reagent.</p></dd></dl><dl class="bkr_refwrap"><dt>7.8.</dt><dd id="ncipr65.lt53"><p class="no_top_margin">Add 100 μL of the Griess reagent to each well of the “NO<sup>−</sup> Test Plate”.</p></dd></dl><dl class="bkr_refwrap"><dt>7.9.</dt><dd id="ncipr65.lt54"><p class="no_top_margin">Mix the well contents using a plate shaker for 2-3 minutes.</p></dd></dl><dl class="bkr_refwrap"><dt>7.10.</dt><dd id="ncipr65.lt55"><p class="no_top_margin">Measure absorbance at 550 nm.</p></dd></dl></dl></div><div id="ncipr65.s8"><h2 id="_ncipr65_s8_">8. Calculations</h2><dl id="ncipr65.l9" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>8.1.</dt><dd id="ncipr65.lt56"><p class="no_top_margin">Percent Coefficient of Variation (%CV)</p><p>The % CV is used to control precision and calculated for each control or test sample according to the following formula:
|
|
<div class="pmc_disp_formula whole_rhythm clearfix" id="ncipr65.deq3"><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow twelve_col"><math id="ncipr65.eq3" display="block"><mi>%</mi><mi>C</mi><mi>V</mi><mo>=</mo><mfrac><mrow><mi>s</mi><mi>t</mi><mi>a</mi><mi>n</mi><mi>d</mi><mi>a</mi><mi>r</mi><mi>d</mi><mtext> </mtext><mi>d</mi><mi>e</mi><mi>v</mi><mi>i</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><mi>n</mi></mrow><mrow><mi>m</mi><mi>e</mi><mi>a</mi><mi>n</mi></mrow></mfrac><mo>*</mo><mn>100</mn><mi>%</mi></math></div><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow last bk_equ_label "><div><span class="nowrap"></span></div></div></div>
|
|
</p></dd></dl><dl class="bkr_refwrap"><dt>8.2.</dt><dd id="ncipr65.lt57"><p class="no_top_margin">Percent Difference From Theoretical (PDFT)</p><p>PDFT is used to control accuracy of the assay calibration standards and quality controls, and is calculated according to the following formula:
|
|
<div class="pmc_disp_formula whole_rhythm clearfix" id="ncipr65.deq4"><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow twelve_col"><math id="ncipr65.eq4" display="block"><mi>P</mi><mi>D</mi><mi>F</mi><mi>T</mi><mo>=</mo><mfrac><mrow><mfenced><mrow><mi>C</mi><mi>a</mi><mi>l</mi><mi>c</mi><mi>u</mi><mi>l</mi><mi>a</mi><mi>t</mi><mi>e</mi><mi>d</mi><mtext> </mtext><mi>N</mi><mi>a</mi><mi>N</mi><msub><mi>O</mi><mn>2</mn></msub><mtext> </mtext><mi>C</mi><mi>o</mi><mi>n</mi><mi>c</mi><mi>e</mi><mi>n</mi><mi>t</mi><mi>r</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><mi>n</mi><mo>−</mo><mi>T</mi><mi>h</mi><mi>e</mi><mi>o</mi><mi>r</mi><mi>e</mi><mi>t</mi><mi>i</mi><mi>c</mi><mi>a</mi><mi>l</mi><mtext> </mtext><mi>N</mi><mi>a</mi><mi>N</mi><msub><mi>O</mi><mn>2</mn></msub><mtext> </mtext><mi>C</mi><mi>o</mi><mi>n</mi><mi>c</mi><mi>e</mi><mi>n</mi><mi>t</mi><mi>r</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><mi>n</mi></mrow></mfenced></mrow><mrow><mi>T</mi><mi>h</mi><mi>e</mi><mi>o</mi><mi>r</mi><mi>e</mi><mi>t</mi><mi>i</mi><mi>c</mi><mi>a</mi><mi>l</mi><mtext> </mtext><mi>N</mi><mi>a</mi><mi>N</mi><msub><mi>O</mi><mn>2</mn></msub><mtext> </mtext><mi>C</mi><mi>o</mi><mi>n</mi><mi>c</mi><mi>e</mi><mi>n</mi><mi>t</mi><mi>r</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><mi>n</mi></mrow></mfrac><mo>*</mo><mn>100</mn><mi>%</mi></math></div><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow last bk_equ_label "><div><span class="nowrap"></span></div></div></div>
|
|
</p></dd></dl></dl></div><div id="ncipr65.s9"><h2 id="_ncipr65_s9_">9. Acceptance Criteria</h2><dl id="ncipr65.l10" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>9.1.</dt><dd id="ncipr65.lt58"><p class="no_top_margin">The %CV for each control and test sample should be within 30%.</p></dd></dl><dl class="bkr_refwrap"><dt>9.2.</dt><dd id="ncipr65.lt59"><p class="no_top_margin">If the positive control fails to meet acceptance criterion described in 9.1, the assay should be repeated.</p></dd></dl><dl class="bkr_refwrap"><dt>9.3.</dt><dd id="ncipr65.lt60"><p class="no_top_margin">Within the acceptable assay, if two of three replicates of unknown sample fail to meet acceptance criterion described in 9.1, this unknown sample should be re-analyzed.</p></dd></dl><dl class="bkr_refwrap"><dt>9.4.</dt><dd id="ncipr65.lt61"><p class="no_top_margin">If two duplicates of the same study sample demonstrate results >30% different, this sample should be reanalyzed.</p></dd></dl><dl class="bkr_refwrap"><dt>9.5.</dt><dd id="ncipr65.lt62"><p class="no_top_margin">The %CV and PDFT of calibration standards and quality controls should be within 20%. At least five calibrators should be available. Four of six QC and at least one of each level should be acceptable. If not, a new set of calibration standards and quality controls should be prepared, and test samples re-loaded onto a new plate.</p></dd></dl></dl></div><div id="ncipr65.rl.r1"><h2 id="_ncipr65_rl_r1_">10. References</h2><dl class="temp-labeled-list"><dl class="bkr_refwrap"><dt>1.</dt><dd><div class="bk_ref" id="ncipr65.ref1">Current Protocols in Immunology. Edited by: John E.
|
|
Coligan (NIAID, NIH); Barbara
|
|
Bierer (Brigham & Women’s Hospital); David H.
|
|
Margulies (NIAID, NIH); Ethan M.
|
|
Shevach (NIAID, NIH); Warren
|
|
Strober (NIAID, NIH); Richard
|
|
Coico (Weill Medical College of Cornell University); John Wiley & Sons, Inc., 2005.</div></dd></dl><dl class="bkr_refwrap"><dt>2.</dt><dd><div class="bk_ref" id="ncipr65.ref2">Standard practice for evaluation of immune responses in biocompatibility testing using ELISA tests, lymphocytes proliferation, and cell migration. ASTM F1906-98.</div></dd></dl><dl class="bkr_refwrap"><dt>3.</dt><dd><div class="bk_ref" id="ncipr65.ref3">Wink, D. A., Hines, H. B., Cheng, R. Y., Switzer, C. H., Flores-Santana, W., Vitek, M. P., Ridnour, L. A., & Colton, C. A. (2011). Nitric oxide and redox mechanisms in the immune response. Journal of leukocyte biology, 89(6), 873–891.
|
|
[<a href="/pmc/articles/PMC3100761/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3100761</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21233414" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 21233414</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>4.</dt><dd><div class="bk_ref" id="ncipr65.ref4">Dobrovolskaia
|
|
MA, McNeil
|
|
SE. Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. J Control Release. 2013
|
|
Dec
|
|
10;172(2):456–66.
|
|
[<a href="/pmc/articles/PMC5831149/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5831149</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23742883" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23742883</span></a>]</div></dd></dl></dl></div><div id="ncipr65.s10"><h2 id="_ncipr65_s10_">11. Abbreviations</h2><dl><dt id="ncipr65.abb_DL1_DI1">Cal</dt><dd><p>calibration standards</p></dd><dt id="ncipr65.abb_DL1_DI2">CV</dt><dd><p>coefficient of variation</p></dd><dt id="ncipr65.abb_DL1_DI3">FBS</dt><dd><p>fetal bovine serum</p></dd><dt id="ncipr65.abb_DL1_DI4">HBSS</dt><dd><p>Hank’s buffered saline solution</p></dd><dt id="ncipr65.abb_DL1_DI5">LPS</dt><dd><p>lipopolysaccharide</p></dd><dt id="ncipr65.abb_DL1_DI6">NC</dt><dd><p>negative control</p></dd><dt id="ncipr65.abb_DL1_DI7">PBS</dt><dd><p>phosphate buffered saline</p></dd><dt id="ncipr65.abb_DL1_DI8">PDFT</dt><dd><p>percent different from theoretical</p></dd><dt id="ncipr65.abb_DL1_DI9">PC</dt><dd><p>positive control</p></dd><dt id="ncipr65.abb_DL1_DI10">QC</dt><dd><p>quality control</p></dd><dt id="ncipr65.abb_DL1_DI11">RPMI</dt><dd><p>Roswell Park Memorial Institute</p></dd><dt id="ncipr65.abb_DL1_DI12">VC</dt><dd><p>vehicle control</p></dd><dt id="ncipr65.abb_DL1_DI13">w/v</dt><dd><p>weight to volume ratio</p></dd></dl></div><div id="ncipr65.app1"><h2 id="_ncipr65_app1_">12. Appendix</h2><div id="ncipr65.app1.fig1" class="figure bk_fig"><div class="graphic"><a href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Example%20Culture%20Plate%20Map.&p=BOOKS&id=604923_ncipr65app1f1.jpg" target="tileshopwindow" class="inline_block pmc_inline_block ts_canvas img_link" title="Click on image to zoom"><div class="ts_bar small" title="Click on image to zoom"></div><img src="/books/NBK604923/bin/ncipr65app1f1.jpg" alt="Example Culture Plate Map." class="tileshop" title="Click on image to zoom" /></a></div><h3><span class="title">Example Culture Plate Map</span></h3></div><div id="ncipr65.app1.fig2" class="figure bk_fig"><div class="graphic"><a href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Example%20NO%02212%20Test%20Plate%20Map.&p=BOOKS&id=604923_ncipr65app1f2.jpg" target="tileshopwindow" class="inline_block pmc_inline_block ts_canvas img_link" title="Click on image to zoom"><div class="ts_bar small" title="Click on image to zoom"></div><img src="/books/NBK604923/bin/ncipr65app1f2.jpg" alt="Example NO− Test Plate Map." class="tileshop" title="Click on image to zoom" /></a></div><h3><span class="title">Example NO<sup>−</sup> Test Plate Map</span></h3></div></div><div><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_top_margin"><p>This protocol assumes an intermediate level of scientific competency with regard to techniques, instrumentation, and safety procedures. Rudimentary assay details have been omitted for the sake of brevity.</p></p></div></dd></dl><dl class="bkr_refwrap"><dt>*</dt><dd><div id="ncipr65.fn1"><p class="no_top_margin">address correspondence to: <a href="mailto:dev@null" data-email="vog.hin.liam@aniram" class="oemail">vog.hin.liam@aniram</a></p></div></dd></dl><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_top_margin"><div>
|
|
<span class="mixed-citation" id="ncipr65.suggestedcitation">Potter TM, Cedrone E, Neun BW, Dobrovolskaia MA, NCL Method ITA-7: Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7. <a href="https://ncl.cancer.gov/resources/assay-cascade-protocols" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">https://ncl.cancer.gov/resources/assay-cascade-protocols</a> DOI: <a href="http://dx.crossref.org/10.17917/T6JC-ZG30" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">10.17917/T6JC-ZG30</a></span>
|
|
</div></p></div></dd></dl></dl></div><div id="bk_toc_contnr"></div></div></div><div class="fm-sec"><h2 id="_NBK604923_pubdet_">Publication Details</h2><h3>Author Information and Affiliations</h3><p class="contrib-group"><h4>Authors</h4><span itemprop="author">Timothy M. Potter</span>, <span itemprop="author">Edward Cedrone</span>, <span itemprop="author">Barry W. Neun</span>, and <span itemprop="author">Marina A. Dobrovolskaia</span><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1</sup>.</p><h4>Contact</h4><div class="affiliation"><sup>1</sup> <span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@aniram" class="oemail">vog.hin.liam@aniram</a></div><div class="affiliation"><sup>1</sup> Nanotechnology Characterization Lab, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, MD 21702</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><h3>Publication History</h3><p class="small">Published: <span itemprop="datePublished">September 2020</span>.</p><h3>Copyright</h3><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div></div><h3>Publisher</h3><p><a href="https://www.cancer.gov/nano/research/ncl" ref="pagearea=page-banner&targetsite=external&targetcat=link&targettype=publisher">National Cancer Institute (US)</a>, Bethesda (MD)</p><h3>NLM Citation</h3><p>Potter TM, Cedrone E, Neun BW, et al. Detection of Nitric Oxide Production by the Macrophage Cell Line RAW264.7: Version 2. 2020 Sep. In: National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols [Internet]. Bethesda (MD): National Cancer Institute (US); 2005 May 1-. NCL Method ITA-7.<span class="bk_cite_avail"></span> doi: 10.17917/T6JC-ZG30</p></div><div class="small-screen-prev"><a href="/books/n/nciprotocols/ncipr80/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="small-screen-next"><a href="/books/n/nciprotocols/ncipr64/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></article><article data-type="table-wrap" id="figobncipr65tab1"><div id="ncipr65.tab1" class="table"><h3><span class="label">Table 1</span><span class="title">Preparation of Calibration Standards</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK604923/table/ncipr65.tab1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ncipr65.tab1_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ncipr65.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Standard</th><th id="hd_h_ncipr65.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Nominal Concentration (μM)</th><th id="hd_h_ncipr65.tab1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Preparation Procedure</th></tr></thead><tbody><tr><td headers="hd_h_ncipr65.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Int. A</td><td headers="hd_h_ncipr65.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">10,000</td><td headers="hd_h_ncipr65.tab1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">100 μL Stock + 900 μL complete medium</td></tr><tr><td headers="hd_h_ncipr65.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Int. B</td><td headers="hd_h_ncipr65.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1000</td><td headers="hd_h_ncipr65.tab1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">100 μL Int. A + 900 μL complete medium</td></tr><tr><td headers="hd_h_ncipr65.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Cal 1</td><td headers="hd_h_ncipr65.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">250</td><td headers="hd_h_ncipr65.tab1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">200 μL Int. B + 600 μL complete medium</td></tr><tr><td headers="hd_h_ncipr65.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Cal 2</td><td headers="hd_h_ncipr65.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">125</td><td headers="hd_h_ncipr65.tab1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">400 μL Cal 1 + 400 μL complete medium</td></tr><tr><td headers="hd_h_ncipr65.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Cal 3</td><td headers="hd_h_ncipr65.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">62.5</td><td headers="hd_h_ncipr65.tab1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">400 μL Cal 2 + 400 μL complete medium</td></tr><tr><td headers="hd_h_ncipr65.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Cal 4</td><td headers="hd_h_ncipr65.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">31.3</td><td headers="hd_h_ncipr65.tab1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">400 μL Cal 3 + 400 μL complete medium</td></tr><tr><td headers="hd_h_ncipr65.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Cal 5</td><td headers="hd_h_ncipr65.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">15.6</td><td headers="hd_h_ncipr65.tab1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">400 μL Cal 4 + 400 μL complete medium</td></tr><tr><td headers="hd_h_ncipr65.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Cal 6</td><td headers="hd_h_ncipr65.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">7.81</td><td headers="hd_h_ncipr65.tab1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">400 μL Cal 5 + 400 μL complete medium</td></tr><tr><td headers="hd_h_ncipr65.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Cal 7</td><td headers="hd_h_ncipr65.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">3.91</td><td headers="hd_h_ncipr65.tab1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">400 μL Cal 6 + 400 μL complete medium</td></tr><tr><td headers="hd_h_ncipr65.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Cal 8</td><td headers="hd_h_ncipr65.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1.95</td><td headers="hd_h_ncipr65.tab1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">400 μL Cal 7 + 400 μL complete medium</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobncipr65tab2"><div id="ncipr65.tab2" class="table"><h3><span class="label">Table 2</span><span class="title">Preparation of Quality Controls</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK604923/table/ncipr65.tab2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ncipr65.tab2_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ncipr65.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Standard</th><th id="hd_h_ncipr65.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Nominal Concentration (μM)</th><th id="hd_h_ncipr65.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Preparation Procedure</th></tr></thead><tbody><tr><td headers="hd_h_ncipr65.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Int. A</td><td headers="hd_h_ncipr65.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">10,000</td><td headers="hd_h_ncipr65.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">100 μL Stock + 900 μL complete medium</td></tr><tr><td headers="hd_h_ncipr65.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Int. B</td><td headers="hd_h_ncipr65.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1000</td><td headers="hd_h_ncipr65.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">100 μL Int. A + 900 μL complete medium</td></tr><tr><td headers="hd_h_ncipr65.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">QC 1</td><td headers="hd_h_ncipr65.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">100</td><td headers="hd_h_ncipr65.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">100 μL Int. B + 900 μL complete medium</td></tr><tr><td headers="hd_h_ncipr65.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">QC 2</td><td headers="hd_h_ncipr65.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">50</td><td headers="hd_h_ncipr65.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">400 μL QC 1 + 400 μL complete medium</td></tr><tr><td headers="hd_h_ncipr65.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">QC 3</td><td headers="hd_h_ncipr65.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">5</td><td headers="hd_h_ncipr65.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">100 μL QC 2 + 900 μL complete medium</td></tr></tbody></table></div></div></article><article data-type="boxed-text" id="figobncipr65box1"><div id="ncipr65.box1" class="box boxed-text-box whole_rhythm hide-overflow"><h3><span class="label">Box 1</span><span class="title">Example Calculation to Determine Nanoparticle Concentration for In Vitro Tests</span></h3><p>In this example, we assume a mouse dose of 123 mg/kg. Therefore, the scaled equivalent human dose would be:
|
|
<div class="pmc_disp_formula whole_rhythm clearfix" id="ncipr65.deq1"><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow twelve_col"><math id="ncipr65.eq1" display="block"><mrow><mi>H</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>d</mi><mi>o</mi><mi>s</mi><mi>e</mi><mo>=</mo><mfrac><mrow><mi>m</mi><mi>o</mi><mi>u</mi><mi>s</mi><mi>e</mi><mtext> </mtext><mi>d</mi><mi>o</mi><mi>s</mi><mi>e</mi></mrow><mrow><mn>12.3</mn></mrow></mfrac><mo>=</mo><mfrac><mrow><mn>123</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>k</mi><mi>g</mi></mrow><mrow><mn>12.3</mn></mrow></mfrac><mo>=</mo><mn>10</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>k</mi><mi>g</mi></mrow></math></div><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow last bk_equ_label "><div><span class="nowrap"></span></div></div></div>
|
|
</p><p>Blood volume constitutes approximately 8% of the body weight. Therefore, an average human of 70 kg body weight has approximately 5.6 L of blood. Assuming all the nanoparticle injected goes into the systemic circulation, this provides a rough approximation of the potential maximum nanoparticle concentration in blood, which is used as the in vitro test concentration.</p><div class="pmc_disp_formula whole_rhythm clearfix" id="ncipr65.deq2"><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow twelve_col">
|
|
<math id="ncipr65.eq2" display="block"><mrow><mi>i</mi><mi>n</mi><mtext> </mtext><mi>v</mi><mi>i</mi><mi>t</mi><mi>r</mi><mi>o</mi><mtext> </mtext><mi>c</mi><mi>o</mi><mi>n</mi><mi>c</mi><mi>e</mi><mi>n</mi><mi>t</mi><mi>r</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><msub><mi>n</mi><mrow><mi>h</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>m</mi><mi>a</mi><mi>t</mi><mi>r</mi><mi>i</mi><mi>x</mi></mrow></msub><mo>=</mo><mfrac><mrow><mi>h</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>d</mi><mi>o</mi><mi>s</mi><mi>e</mi></mrow><mrow><mi>h</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>b</mi><mi>l</mi><mi>o</mi><mi>o</mi><mi>d</mi><mtext> </mtext><mi>v</mi><mi>o</mi><mi>l</mi><mi>u</mi><mi>m</mi><mi>e</mi></mrow></mfrac><mo>=</mo><mfrac><mrow><mn>70</mn><mo> </mo><mi>k</mi><mi>g</mi><mo>*</mo><mn>10</mn><mi>m</mi><mi>g</mi><mo>/</mo><mi>k</mi><mi>g</mi></mrow><mrow><mn>5.6</mn><mo> </mo><mi>L</mi></mrow></mfrac><mo>=</mo><mn>0.125</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>m</mi><mi>L</mi></mrow></math>
|
|
</div><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow last bk_equ_label "><div><span class="nowrap"></span></div></div></div></div></article><article data-type="fig" id="figobncipr65app1fig1"><div id="ncipr65.app1.fig1" class="figure bk_fig"><div class="graphic"><a href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Example%20Culture%20Plate%20Map.&p=BOOKS&id=604923_ncipr65app1f1.jpg" target="tileshopwindow" class="inline_block pmc_inline_block ts_canvas img_link" title="Click on image to zoom"><div class="ts_bar small" title="Click on image to zoom"></div><img data-src="/books/NBK604923/bin/ncipr65app1f1.jpg" alt="Example Culture Plate Map." class="tileshop" title="Click on image to zoom" /></a></div><h3><span class="title">Example Culture Plate Map</span></h3></div></article><article data-type="fig" id="figobncipr65app1fig2"><div id="ncipr65.app1.fig2" class="figure bk_fig"><div class="graphic"><a href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Example%20NO%02212%20Test%20Plate%20Map.&p=BOOKS&id=604923_ncipr65app1f2.jpg" target="tileshopwindow" class="inline_block pmc_inline_block ts_canvas img_link" title="Click on image to zoom"><div class="ts_bar small" title="Click on image to zoom"></div><img data-src="/books/NBK604923/bin/ncipr65app1f2.jpg" alt="Example NO− Test Plate Map." class="tileshop" title="Click on image to zoom" /></a></div><h3><span class="title">Example NO<sup>−</sup> Test Plate Map</span></h3></div></article></div><div id="jr-scripts"><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/libs.min.js"> </script><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.min.js"> </script><script type="text/javascript" src="/core/mathjax/2.7.9/MathJax.js?config=TeX-AMS-MML_SVG"> </script></div></div>
|
|
|
|
|
|
|
|
|
|
<!-- Book content -->
|
|
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal107 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3968615.js" snapshot="books"></script></body>
|
|
</html>
|